Institutional Ownership Mirum Pharmaceuticals, Inc. (MIRM)
This table provides information about the institutional ownership of Mirum Pharmaceuticals, Inc. (MIRM). We have compiled data on the 211 institutions that hold shares in the stock, with a total of 53.8 Million shares, which have been reported (via 13F filing form) to have a value of $2.53 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Feb 14, 2025 Q4 2024 |
6,570,392
shares
|
$313 Million
16.29% of portfolio
|
Q3 2024
Added 1.15%
|
|
|
Janus Henderson Group PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
4,581,642
shares
|
$218 Million
0.1% of portfolio
|
Q4 2024
Added 2.26%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
3,238,049
shares
|
$154 Million
0.0% of portfolio
|
Q2 2024
Added 32.04%
|
|
|
Bvf Inc
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
2,796,513
shares
|
$133 Million
4.33% of portfolio
|
Q4 2024
Reduced 9.08%
|
|
|
Eventide Asset Management, LLC
Boston, MA |
Feb 14, 2025 Q4 2024 |
2,606,938
shares
|
$124 Million
2.07% of portfolio
|
Q4 2024
Reduced 24.33%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
2,424,734
shares
|
$115 Million
0.0% of portfolio
|
Q4 2024
Reduced 2.86%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
1,511,183
shares
|
$71.9 Million
0.01% of portfolio
|
Q4 2024
Added 8.61%
|
|
|
Novo Holdings
Hellerup, G7 |
Feb 14, 2025 Q4 2024 |
1,500,000
shares
|
$71.4 Million
5.04% of portfolio
|
Q3 2023
Reduced 10.94%
|
|
|
Rock Springs Capital Management LP
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
1,471,564
shares
|
$70 Million
2.43% of portfolio
|
Q4 2024
Reduced 6.89%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
1,422,729
shares
|
$67.7 Million
0.01% of portfolio
|
Q4 2024
Added 10.8%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,381,627
shares
|
$65.7 Million
0.0% of portfolio
|
Q4 2024
Reduced 22.97%
|
|
|
Tang Capital Management LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
1,237,107
shares
|
$58.8 Million
3.84% of portfolio
|
Q4 2024
Reduced 3.88%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
943,344
shares
|
$44.9 Million
0.0% of portfolio
|
Q4 2024
Added 0.76%
|
|
|
Clearbridge Investments, LLC
New York, NY |
Feb 12, 2025 Q4 2024 |
907,317
shares
|
$43.2 Million
0.03% of portfolio
|
Q4 2024
Added 2.05%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
883,979
shares
|
$42.1 Million
0.03% of portfolio
|
Q2 2023
Added 9.93%
|
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Feb 12, 2025 Q4 2024 |
860,096
shares
|
$40.9 Million
0.04% of portfolio
|
Q4 2024
Reduced 3.97%
|
|
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
Feb 14, 2025 Q4 2024 |
782,354
shares
|
$37.2 Million
0.1% of portfolio
|
Q4 2024
Added 5.53%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
758,380
shares
|
$36.1 Million
0.0% of portfolio
|
Q4 2024
Added 21.16%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
722,155
shares
|
$34.4 Million
0.01% of portfolio
|
Q4 2024
Added 46.66%
|
|
|
Polar Capital Holdings PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
675,000
shares
|
$32.1 Million
0.17% of portfolio
|
Q3 2024
Reduced 8.91%
|
|
|
Avidity Partners Management LP
Dallas, TX |
Feb 14, 2025 Q4 2024 |
666,200
shares
|
$31.7 Million
3.11% of portfolio
|
Q4 2024
Reduced 8.88%
|
|
|
Franklin Resources Inc
San Mateo, CA |
Feb 12, 2025 Q4 2024 |
590,662
shares
|
$28.1 Million
0.01% of portfolio
|
Q4 2024
Reduced 0.34%
|
|
|
Bio Impact Capital LLC
Cambridge, MA |
Feb 14, 2025 Q4 2024 |
589,579
shares
|
$28 Million
3.65% of portfolio
|
Q4 2024
Added 19.66%
|
|
|
Boone Capital Management LLC
Atlanta, GA |
Feb 14, 2025 Q4 2024 |
581,843
shares
|
$27.7 Million
8.12% of portfolio
|
Q4 2024
Added 6.99%
|
|
|
Loomis Sayles & CO L P
|
Feb 12, 2025 Q4 2024 |
578,024
shares
|
$27.5 Million
0.03% of portfolio
|
Q4 2024
Added 15.76%
|